Skip to main content
Livermore
Livermore
ZHEN

ProShare Advisors LLC

SEC CIK
0001357955
Latest filing
Aug 11, 2026

IMVT holding history

Immunovant, Inc. in every 13F filed by ProShare Advisors LLC, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

IMVT overviewAll 13F holders of IMVTFull Q2 2026 holdings

Shares (Q2 2026)
17,904
Value
$689.8K
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of IMVT by ProShare Advisors LLC, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202617,904$689.8K<0.1%−3,017−14.4%ReducedHolders
Q1 202620,921$519.7K<0.1%+368+1.8%AddedHolders
Q4 202520,553$522.5K<0.1%+2,660+14.9%AddedHolders
Q3 202517,893$288.4K<0.1%−2,500−12.3%ReducedHolders
Q2 202520,393$326.3K<0.1%+165+0.8%AddedHolders
Q1 202520,228$345.7K<0.1%−3,072−13.2%ReducedHolders
Q4 202423,300$577.1K<0.1%+3,681+18.8%AddedHolders
Q3 202419,619$559.3K<0.1%+3,375+20.8%AddedHolders
Q2 202416,244$428.8K<0.1%−3,633−18.3%ReducedHolders
Q1 202419,877$642.2K<0.1%+1,703+9.4%AddedHolders
Q4 202318,174$765.7K<0.1%+2,620+16.8%AddedHolders
Q3 202315,554$597.1K<0.1%+99+0.6%AddedHolders
Q2 202315,455$293.2K<0.1%+1,193+8.4%AddedHolders
Q1 202314,262$221.2K<0.1%−2,147−13.1%ReducedHolders
Q4 202216,409$291.3K<0.1%+2,186+15.4%AddedHolders
Q3 202214,223$80.0K<0.1%+659+4.9%AddedHolders
Q2 202213,564$53.0K<0.1%−6,090−31.0%ReducedHolders
Q1 202219,654$108.0K<0.1%−5,301−21.2%ReducedHolders
Q4 202124,955$212.0K<0.1%−4,746−16.0%ReducedHolders
Q3 202129,701$258.0K<0.1%+2,366+8.7%AddedHolders
Q2 202127,335$289.0K<0.1%+3,758+15.9%AddedHolders
Q1 202123,577$378.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.